Related Experiment Video

Updated: Apr 18, 2026

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

3.1K

Pharmacological characterization of conotoxin lt14a as a potent non-addictive analgesic

Zhenghua Ren1, Lei Wang1, Mengying Qin1

  • 1State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, National Engineering Research Center of South China Sea Marine Biotechnology, Department of Biochemistry, College of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, People's Republic of China.

Toxicon : Official Journal of the International Society on Toxinology
|January 25, 2015
PubMed

Insights

Conotoxin lt14a, a novel peptide, demonstrates significant antinociceptive effects by targeting nicotinic acetylcholine receptors (nAChRs). This compound alleviates pain and withdrawal symptoms without causing drug dependence.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Marine Biology

Background:

  • Conotoxin lt14a, a 13-amino acid peptide from Conus litteratus, has shown potential antinociceptive activity.
  • Previous studies indicated lt14a acts as an antagonist of neuronal nicotinic acetylcholine receptors (nAChRs).

Purpose of the Study:

  • To confirm and further investigate the antinociceptive properties of conotoxin lt14a.
  • To elucidate the mechanism of action of lt14a, including its interaction with nAChRs and downstream signaling pathways.
  • To assess the potential for drug dependence and effects on opioid withdrawal.

Main Methods:

  • Administration of lt14a in mouse inflammatory and rat mechanical pain models.
  • Analysis of c-fos and NOS mRNA expression in rat spinal cords.
  • Fluorescent labeling of lt14a and binding assays with PC12 cells.
  • Patch clamp whole-cell recordings to study nAChR interactions.
  • Assessment of extracellular signal-regulated kinase (ERK1/2) phosphorylation.
  • Evaluation of drug dependence and morphine withdrawal symptoms.

Main Results:

  • Conotoxin lt14a demonstrated significant antinociception in inflammatory and mechanical pain models.
  • lt14a suppressed spinal cord mRNA expression of c-fos and NOS.
  • lt14a binding to PC12 cells was confirmed to be mediated by nAChRs, inhibited by antagonists.
  • lt14a suppressed acetylcholine-induced ERK1/2 phosphorylation.
  • lt14a did not induce drug dependence and attenuated morphine withdrawal symptoms.

Conclusions:

  • Conotoxin lt14a is a potent antinociceptive agent targeting nAChRs.
  • lt14a exerts its effects through modulation of neuronal signaling pathways.
  • lt14a represents a promising therapeutic candidate for pain management without the risk of dependence.
Keywords:
AnalgesicConotoxinDrug addictionLt14anAChR

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 109:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K
Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

6.0K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
4.6K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
7.3K